Results of the CPTAC data showed that TRMT112 proteins in colon cancer, ovarian cancer, and clear cell renal cell carcinoma samples were more abundant relative to that in the respective normal control (Figure 1(c), P < 0.001). This evidence concerns the gene TRMT112 and ovarian carcinoma.